Skip to content
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
SV
EN
Press releases
Start
/
Newsroom
/
Press releases
Press releases
News
Investor letter
Media bank
Press releases
News
Investor letter
Media bank
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2019
2019-05-23 12:42
Preliminary results from SpectraCure's prostate treatments
Regulatory
MAR
2019-04-10 10:46
New patient treatment, phase 2 initiated
Regulatory
MAR
2019-04-05 13:53
SpectraCure files for a new patent
Regulatory
MAR
2019-03-29 15:49
Status report for phase 2 study
Regulatory
2019-03-01 08:37
Final preparation for Phase 2 - SpectraCure extends contract with hospital in London
Regulatory
2019-02-15 12:00
SpectraCure AB Year-end report 1 January – 31 December 2018
Regulatory
MAR
2019-02-15 09:22
More results from Phase 1 study
Regulatory
2019-01-28 14:02
Results from clinical study for patient 9 and 10
Regulatory
MAR
2018
2018-12-21 10:36
SpectraCure receives prestigious grant from the Eurostars program
Regulatory
MAR
2018-12-17 14:57
SpectraCure one step closer to Phase 2 after successful treatment effect in recent patients
Previous
Next